Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Demant A/S

Demant is a global hearing healthcare and audio technology group that develops hearing health solutions and offers related products and services.

msh id	COM:DEMANT
symbol	DEMANT
name	Demant A/S
homepage url	https://www.demant.com
country	DK
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	21.62K
crunchbase url	-
linkedin url	-
founders	-

market cap	9.46B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	143.61K
monthly webtraffic growth	0.18
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.1
growth cost of revenue	0.17
growth depreciation and amortization	0.22
growth ebitda	0.23
growth ebitda ratio	0.08
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.1
growth gross profit	0.13
growth gross profit ratio	-0.01

DEMA

COM:DEMANT

Demant

Last Close

259.60

21/11 15:59

Market Cap

65.31B

Beta: -

Volume Today

261.21K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	2.66B
cost of revenue	2.66B
depreciation and amortization	193.04M
ebitda	765.06M
ebitda ratio	0.24
eps	1.16
eps diluted	1.16
operating expenses	1.8B
operating income	600.24M
operating income ratio	0.18

accounts receivables	-12.3M
capital expenditure	-122.42M
cash at beginning of period	163.52M
cash at end of period	164.67M
inventory	411.69M
working capital ttm	271M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-